166 filings
6-K
GNFT
Genfit
25 Apr 24
Current report (foreign)
4:10pm
6-K
GNFT
Genfit
15 Apr 24
Current report (foreign)
4:10pm
6-K
GNFT
Genfit
5 Apr 24
GENFIT Announces Publication of the 2023 Universal Registration Document and the 2023 Annual Report on Form 20-F
2:03pm
20-F
2023 FY
GNFT
Genfit
Annual report (foreign)
5 Apr 24
11:44am
6-K
GNFT
Genfit
4 Apr 24
GENFIT Reports Full-Year 2023 Financial Results and Provides Corporate Update
4:45pm
6-K
GNFT
Genfit
29 Feb 24
Current report (foreign)
4:10pm
SC 13G/A
GNFT
Genfit
14 Feb 24
Genfit / TANG CAPITAL PARTNERS ownership change
4:00pm
6-K
GNFT
Genfit
17 Jan 24
GENFIT Announces 2024 Financial Calendar
6:00am
6-K
GNFT
Genfit
11 Jan 24
Current report (foreign)
4:10pm
6-K
GNFT
Genfit
8 Dec 23
Current report (foreign)
8:00am
6-K
GNFT
Genfit
7 Dec 23
Ipsen confirms U.S. FDA grants priority review for New Drug Application for elafibranor for the treatment of rare cholestatic liver disease, PBC
6:37am
6-K
GNFT
Genfit
6 Dec 23
Current report (foreign)
11:30am
6-K
GNFT
Genfit
16 Nov 23
GENFIT Highlights ACLF Development Strategy at “ACLF Day” during AASLD The Liver Meeting® 2023
4:10pm
6-K
GNFT
Genfit
13 Nov 23
Current report (foreign)
4:30pm
6-K
GNFT
Genfit
9 Nov 23
GENFIT Reports Third Quarter 2023 Financial Information
4:10pm
6-K
GNFT
Genfit
6 Nov 23
GENFIT to Present Update on Scientific and Corporate Progress at The Liver Meeting® 2023
7:00am
6-K
GNFT
Genfit
26 Sep 23
GENFIT Announces Publication in Nature Medicine Confirming the Performance of its NASH Diagnostic Technology
4:10pm
6-K
GNFT
Genfit
20 Sep 23
GENFIT Reports First Half-Year 2023 Financial Results and Provides Corporate Update
4:51pm
6-K
GNFT
Genfit
20 Sep 23
Current report (foreign)
4:44pm
6-K
GNFT
Genfit
5 Sep 23
GENFIT to Participate in Upcoming Investor Conferences
4:10pm